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Abstract
Owing to the growth direction of cholangiocellular carcinomas along the bile ducts, these tumors are often detected in a
late stage. Klatskin tumors are mostly presented by jaundice. In cases of advanced inoperable tumors, a palliative photo-
dynamic therapy (PDT) is possible. The aim of a PDT is a selective destruction of tumor tissue caused by the activation of
photosensitizers by laser light. After the application of photosensitizers, they accumulate in the tumor and photochemistry
reactions start by the inﬂuence of laser light. This leads to tumor necrosis. A common photosensitizer for cholangiocellular
carcinomas is photofrin. After a PDT, it is necessary to perform light protection for nearly 2 months.
The authors present a case of a patient who underwent percutaneous transhepatic cholangioscopy and palliative PDT of a
cholangiocellular carcinoma (Klatskin tumor). This article is part of an expert video encyclopedia.
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Video Related to this Article
Technique
Percutaneous transhepatic cholangioscopy with photodyna-
mic therapy (PDT).
Materials
Percutaneous cholangioscope (Olympus, CHP30, Tokyo,
Japan), PDT probe (Biolitec, East Longmeadow, MA, USA),
Laser system (Ceralas, 633 nm, East Longmeadow, MA, USA),
Chiba ﬁne needle, puncture cannula, guide wire, Nimura
catheter (all Pﬂugbeil Corp., Zorneding, Germany).
Endoscopic Procedure
Owing to the growth direction of cholangiocellular carcin-
omas along the bile ducts, these tumors are often detected in a
late stage. Klatski-tumors are mostly presented by jaundice. In
cases of advanced inoperable tumors, a palliative PDT is
possible. The aim of PDT is a selective destruction of tumor
tissue. To perform a PDT, an administration of a photo-
sensitizer is a prerequisite. The photosensitizer concentrates in
tumor tissue and remains inactive until exposed to a speciﬁc
wavelength of light.1 This leads to tumor necrosis. A common
photosensitizer for cholangiocellular carcinomas is photofrin.
After PDT, it is necessary to perform light protection for nearly
2 months. The PDT can lead to a survival beneﬁt2,3 and to a
better quality of life.4,5
The authors present a case of a 72-year-old male patient
who underwent percutaneous transhepatic cholangioscopy
(PTCS) and palliative PDT of a cholangiocellular carcinoma
(Klatskin tumor). Abdominal ultrasound revealed dilated
right- and left-sided intrahepatic bile ducts and a tumor in the
hepatic bifurcation Bismuth IV. The authors decided to per-
form a therapeutic endoscopic retrograde cholangiography
(ERC) for stenting, but it was not possible to place a stent
across the tumor because of its extensive size. Therefore, the
authors decided to perform percutaneous transhepatic bile
duct drainage (PTCD). Four weeks later, the authors ad-
ministered photofrin as a photosensitizer to start the PDT.
After 48 h, the authors performed PTCS over the preexisting
percutaneous biliary ﬁstula and started the palliative PDT.
After skin disinfection and sterile covering, the patient was
premedicated with midazolam and pethidin and a local
anesthesia with lidocaine was performed.
Then the insertion of the sterile cholangioscope (4.9 mm)
under permanent water injection over a guide wire was pos-
sible. It is important to prevent air insufﬂation as there were
described cases of air embolization. A large tumor was visible
in the distal right ductus hepaticus under direct videoendo-
scopy. To start the palliative PDT of the tumor, the authors
introduced the PDT probe up to the tumor and started the
procedure under cholangioscopic control. After that, the
authors implanted a drainage device to prevent jaundice from
tissue swelling.
Key Learning Points/Tips and Tricks
• In some cases, an endoscopic cholangiography is not
possible, and then a percutaneous procedure (PTCS) can
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be inevitable. The other option is endoscopic retrograde
cholangiopancreatography (ERCP) with a special dedicated
single- or double-balloon enteroscopy by pure endo-
scopic means.
• It is necessary to work sterile to prevent infection; a
prophylactic antibiotic therapy could be helpful.
• The insertion of the cholangioscope is easier over a guide
wire and under ﬂuoroscopy.
• To perform a PDT, an administration of a photosensitizer is
a prerequisite. The photosensitizer concentrates in tumor
tissue and remains inactive until exposed to a speciﬁc
wavelength of light.1 The PDT can lead to a survival
beneﬁt2,3 and to a better quality of life.4,5
• The photosensitizer has to be administered 48 h before
starting the photodynamic therapy.
• After the PDT, it is necessary to perform a consequent light
protection more than 6–8 weeks.
Complications and Risk Factors
One complication in PDT is phototoxicity, which can be
prevented by avoiding direct sunlight exposure for a different
time interval due to the type of the photosensitizer.1 In case of
photofrin, a light protection more than 6–8 weeks is
necessary.6
Alternatives
• In palliation of biliary tumors, different methods are de-
scribed. The performance of stent or drainage implantation
is widely spread. The different types of stents are dis-
tinguished in plastic stents, self-expandable metal stents,
and drug-eluting stents, just to name a few.
• Other methods in palliation of biliary tumors are intra-
luminal high-dose brachytherapy, systemic chemotherapy,
radiotherapy, and palliative surgery.
Scripted Voiceover
Time (min:sec) Voiceover text
00:00 A 72-year-old male patient was admitted because of
jaundice. Caused by the extensive size of a
Klatskin tumor a palliative stent-implantation by
endoscopic retrograde cholangiography (ERC)
was not successful so that we performed a
percutaneous transhepatic bile duct drainage
(PTCD). After 4 weeks he underwent
percutaneous transhepatic cholangioscopy
(PTCS) and palliative photodynamic therapy
(PDT) of a cholangiocellular carcinoma (Klatskin-
tumor). Therefor we insert a sterile
cholangioscope over the present cutaneous-
biliary ﬁstula into the bile duct.
00:20 The cholangioscope is inserted forward to the
tumor under water injection with the help of a
guide wire.
00:29 The tumor is visible; recognizable based on its
unregular surface, tumor-vessels and contact
vulnerability.
00:34 The PDT-probe is pushed forward to the tumor.
00:36 And the photodynamic therapy starts.
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